For the seventh consecutive year (2009-15), the Northside BMT Program
achieved survival outcomes that significantly exceeded the expected
range as reported in the 2015 Center for International Blood and
Marrow Transplant Research and the National
Marrow Donor Program data release. There were 173 adult and
pediatric transplant centers included in the analysis. [*1]
Northside’s BMT Program was:
Our BMT Program is nationally accredited by the following organizations:
We have received many accolades including the national Center of Excellence recognition from the health care insurance industry. We are among the elite preferred Center of Excellence transplant programs in the United States, as designated by most national health care insurance companies, and we serve as a tertiary referral center for patients in Georgia and nationwide.
[*1] Reported outcome data from bethematch.org. This survival information includes only patients who received their first allogeneic transplant between January 1, 2011 and December 31, 2013 using unrelated or related donors, and who had reported follow-up.
[*2] Final 2015 Transplant Center Specific Survival Report, December 16, 2015.